ClinicalTrials.Veeva

Menu

Memantine in Patients With Chronic Glaucoma

Allergan logo

Allergan

Status and phase

Completed
Phase 3

Conditions

Open-Angle Glaucoma

Treatments

Drug: memantine

Study type

Interventional

Funder types

Industry

Identifiers

NCT00168350
192944-005

Details and patient eligibility

About

Randomized double-masked clinical trial of memantine in patients with glaucoma

Enrollment

1,179 patients

Sex

All

Ages

18 to 82 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • glaucoma damage on examination of visual field and optic disc
  • good visual acuity (with glasses if needed)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems